New: NCI-funded clinical trial search
Mednet Logo

How do you manage patients with primary refractory Hodgkin lymphoma?

If a patient has an increase in PET avidity between the PET/CT done after 2 cycles of ABVD and after completion of chemo, how would you proceed? Would you consolidate RT to the PET avid disease sites? Would it be better to refer for salvage chemo +/- AutoBMT? Would a biopsy of the PET avid sites be indicated?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on

Without advising directly on this particular case, which is difficult to do without more information, a few principles in lymphoma management may be helpful:

1. Whenever there is discordance in the clinical picture, or whenever initial management would be drastically changed, it is always prudent to perform a biopsy to confirm what you suspect. It is typically less important which site you biopsy, though in general you want to target a lesion that has both an anatomical and PET correlate.

2. PET-CT imaging is imperfect. Beware of making clinical decisions solely on the results of imaging. While PET-CT is a sensitive modality, the specificity is less dependable.

3. If lymphoma is progressing through systemic therapy (e.g., new sites of disea...

Join for free or sign in to see the full answer